Open AccessChronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threat
Author(s) -
Dukhabandhu Naik,
Anjali Joshi,
Thomas Paul,
Nihal Thomas
Publication year - 2014
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/2230-8210.139212
Subject(s) - medicine , metabolic syndrome , copd , insulin resistance , pulmonary disease , obesity , disease , systemic inflammation , inflammation , diabetes mellitus , skeletal muscle , intensive care medicine , endocrinology
The metabolic syndrome is found to be more frequent in chronic obstructive pulmonary disease (COPD). The presence of inflammatory markers in circulation, sputum, and broncho-alveolar fluid suggest systemic inflammation is one of the potential mechanisms responsible for both COPD and metabolic syndrome. Physical inactivity, skeletal muscle dysfunction, hypogonadism, and steroid use are also important causes of the metabolic syndrome in COPD. Obesity and insulin resistance is found to be more common in mild to moderate stages (I and II) of COPD. Patients with COPD and the metabolic syndrome have increase risk of morbidity and mortality due to cardiovascular disease. This review describes in details the various components of metabolic syndrome and its impact on long outcomes in COPD patients.